Mass spectrometry to analyse Covid-19 samples

University of Surrey

Mass spectrometry to analyse Covid-19 samples

Researchers from the University of Surrey are applying specialist skills in mass spectrometry to assist in accelerating the search for a Covid-19 vaccine. The team is taking ground-breaking techniques recently developed to deliver fast cocaine and heroin fingerprint testing technology and applying them to the analysis of test samples taken from Covid-19 patients.

The team answered a call from the British Mass Spectrometry Society, led by Professor Perdita Barran from the University of Manchester, for experts in this field of science to join together and analyse Covid-19 to help the wider scientific community gain a better understanding of the virus.

Surrey will be receiving samples from Frimley Park Hospital, with analysis starting immediately.

Dr Melanie Bailey, Reader in Forensic Analysis at the University of Surrey, said: “Like many people across the world, we want to do everything we can to stop the spread of this terrible virus. We believe the mass spectrometry expertise we have recently applied to rapid testing techniques for cocaine and heroin can be quickly applied to support our partners to develop a vaccine or therapeutic drugs that can ease some of the symptoms in Covid-19 patients.”

Professor Deborah Dunn-Waters from the University of Surrey said: “Monitoring the immune response to Covid-19 can help us to determine why some people get more poorly than others and provide important information for the vaccinologists to use.  We are glad we can contribute to the Covid-19 research effort and are extremely grateful to our amazing NHS colleagues at Frimley Park Hospital for all their help with this.”

Source: University of Surrey

17.05.2020

More on the subject:
Read all latest stories

Related articles

Photo

Lack of support

Frontline healthcare workers: Covid heroes – or cannon fodder?

A large-scale qualitative study looks into the difficulties frontline doctors faced across two waves of the Covid-19 pandemic in the UK and Ireland since early 2020.

Photo

Covid-19 protection

Needle-free coronavirus vaccine enters clinical trial

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting Covid-19 virus variants and relatives that threaten future coronavirus pandemics.

Photo

Gender equality in clinical trials

Women in Covid-19 research: a good start, but...

There has been a "positive shift" in inclusive gender practices in Covid-19 vaccine research, but there is still room for improvement, experts say. Women have been equally recruited and…

Related products

Beckman Coulter – SARS-CoV-2 Assays

Immunoassays

Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Lifotronic  SARS-CoV-2 Antibody Detection Kit

Immunoassays

Lifotronic SARS-CoV-2 Antibody Detection Kit

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Antigen

Immunoassays

Lifotronic – SARS-CoV-2 Antigen

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Detection

Lifotronic – SARS-CoV-2 Nucleic Acid Detection Kit

Lifotronic Technology Co., Ltd
Subscribe to Newsletter